Literature DB >> 24323138

Community child psychiatric medication experiences measured by an internet-based, prospective parent survey of retail pharmacy customers.

Robert Hilt1, Christine Wolf, Kent Koprowicz, Elizabeth Thomas, Mary Chandler, Xiao Lei Hao, Matthew Russell, Tung Le, Lee Hooks, Bryan King.   

Abstract

One thousand five hundred parents filling a psychiatric prescription for their 6-18 year old child with a multi-state retail pharmacy chain received a single mailed invitation to complete a detailed online survey. 276 parents responded (18.4%). 60% of children on medications had a parent rated CBCL scale score in the clinically significant range at enrollment (T score ≥65), with a similar frequency of clinically significant CBCL scores through 15 months of survey followup. 47% of medication regimens were noted to be causing persistent side effects. This simple community based data collection method can offer a unique way to investigate naturalistic treatment outcomes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24323138     DOI: 10.1007/s10597-013-9671-x

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  12 in total

1.  A comparison of observational studies and randomized, controlled trials.

Authors:  K Benson; A J Hartz
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

2.  Psychopharmacology. The medication merry-go-round.

Authors:  Kathryn Brown
Journal:  Science       Date:  2003-03-14       Impact factor: 47.728

Review 3.  Study design and hierarchy of evidence for surgical decision making.

Authors:  Sheila Sprague; Paula McKay; Achilleas Thoma
Journal:  Clin Plast Surg       Date:  2008-04       Impact factor: 2.017

Review 4.  Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes.

Authors:  Christoph U Correll
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-01       Impact factor: 8.829

5.  The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use.

Authors:  Michael Berk; Felicity Ng; Seetal Dodd; Tom Callaly; Shirley Campbell; Michelle Bernardo; Tom Trauer
Journal:  J Eval Clin Pract       Date:  2008-05-02       Impact factor: 2.431

Review 6.  Concomitant psychotropic medication for youths.

Authors:  Daniel J Safer; Julie Magno Zito; Susan DosReis
Journal:  Am J Psychiatry       Date:  2003-03       Impact factor: 18.112

7.  Psychotropic medication use in a national probability sample of children in the child welfare system.

Authors:  Ramesh Raghavan; Bonnie T Zima; Ronald M Andersen; Arleen A Leibowitz; Mark A Schuster; John Landsverk
Journal:  J Child Adolesc Psychopharmacol       Date:  2005-02       Impact factor: 2.576

8.  Prioritizing future research on off-label prescribing: results of a quantitative evaluation.

Authors:  Surrey M Walton; Glen T Schumock; Ky-Van Lee; G Caleb Alexander; David Meltzer; Randall S Stafford
Journal:  Pharmacotherapy       Date:  2008-12       Impact factor: 4.705

9.  Effect of questionnaire length, personalisation and reminder type on response rate to a complex postal survey: randomised controlled trial.

Authors:  Shannon Sahlqvist; Yena Song; Fiona Bull; Emma Adams; John Preston; David Ogilvie
Journal:  BMC Med Res Methodol       Date:  2011-05-06       Impact factor: 4.615

10.  Off-label psychopharmacologic prescribing for children: history supports close clinical monitoring.

Authors:  Julie M Zito; Albert T Derivan; Christopher J Kratochvil; Daniel J Safer; Joerg M Fegert; Laurence L Greenhill
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2008-09-15       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.